Objective: To evaluate the changes in lipid status in children during anticancer therapy, with special reference to the effect of protein ± energy malnutrition on plasma lipids. Design: Prospective follow-up study. Setting: The study was carried out in the Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland Subjects: The study group consisted of 33 children going through bone marrow transplantation (BMT) and 10 children with malignant solid tumors. The BMT patients were evaluated before transplantation and 1 and 3 months after BMT, and the tumor patients were studied at diagnosis and in remission. The reference group consisted of 23 healthy children. Interventions: As indicators of lipid status, lipoproteins and the concentration of cholesterol and triacylglycerol were measured. Protein reserves were expressed as muscle index (MI), derived from ultrasonographic measurement of the femoral quadriceps muscle. Body weight, triceps skinfold thickness and the serum concentration of albumin, prealbumin and transferrin were measured. Results: In both groups, plasma concentration of total triacylglycerol was increased and high-density lipoprotein (HDL) cholesterol decreased as compared to the reference subjects. Plasma triacylglycerol concentration had a negative correlation with skeletal muscle protein mass (MI; r 0.34, P 0.02). The concentration of serum prealbumin correlated positively with plasma total cholesterol concentration (r 0.47, P 0.002). 
Introduction
Glucose, fatty acids, ketone bodies, amino acids and lactate are the fuels for daily energy metabolism. In healthy man, approximately 55 ± 70% of the total energy requirements are delivered as glucose and amino acids (Committee on Nutrition, American Academy of Pediatrics, 1992) . Fasting results in glycogenolysis, and further in breakdown of muscle and in gluconeogenesis. Adaptation to a prolonged starvation leads to conversion from glucose and amino acid consumption to the use of fat-derived substrates (Cahill, 1970) . In cancer patients, this adaptation seems to be incomplete (Young, 1977; Heber et al, 1986) , and gluconeogenesis continues actively, particularly through the energy-consuming Cori cycle from lactate to glucose (Young, 1977) .
Malnutrition is a major problem in patients with cancer. Despite nutritional support, poor nutritional status has a signi®cant effect on survival (Heber et al, 1986; DeWys et al, 1980; Taskinen & Saarinen, 1996) . Metabolic abnormalities interfering the development of malnutrition in cancer patients are increased glucose production in the fasting state, abnormalities in insulin secretion and action, increased whole-body protein breakdown, increased lipolysis, and decreased mass of adipose tissue (Heber et al, 1986; Kern & Norton 1988) . The catabolic state may be due to the malignant disease itself, anticancer therapy or complications of therapy, eg febrile infections.
The lipid abnormalities observed in adult cancer patients are increased concentration of plasma total triacylglycerol (TG) and decreased concentration of plasma high-densitylipoprotein cholesterol (HDL-CH; Spiegel et al 1982; Dilman et al, 1981; Vlassara et al, 1986) . These abnormalities have been explained by decreased activity of the enzyme lipoprotein lipase (LPL; Vlassara et al, 1986) . The similar lipid pro®les in patients suffering from cancer (Spiegel et al, 1982; Dilman et al, 1981; Vlassara et al, 1986 ) and severe protein-energy malnutrition (Sita Devi et al, 1976) raise the question whether lipid abnormalities in cancer patients could originate in protein ± energy malnutrition.
In the present study, we evaluated the plasma lipid status of children during different stages of anticancer therapy. We paid particular attention to the relationship between plasma lipid levels and signs of protein ± energy malnutrition.
Subjects and methods

Patients
We examined 10 consecutive newly-diagnosed children with malignant solid tumors and 39 bone marrow transplant (BMT) patients at the Hospital for Children and Adolescents, University of Helsinki, Finland, between September 1992 and May 1995.
After diagnosis from initial tumor biopsy, the therapeutic strategy in all tumor patients was to give neoadjuvant chemotherapy until desired tumor shrinkage, at which point surgery was employed. The median duration of preoperative chemotherapy was 3.2 months (range 0.1 ± 5.0 months). The patients with Wilms' tumor were treated according to the National Wilms Tumor Study protocols (NWTS III ± IV), the patients with Ewing's sarcoma according to the Intergroup protocol for PNET and Ewing's sarcoma of bone (CCG ± 7881), and the osteosarcoma patient with high-dose-methotrexate, doxorubicin, cisplatin and ifosfamide. For the patient with stage IV neuroblastoma, the drug combinations of cyclophosphamide, dacarbazine and vincristine, and cisplatin plus doxorubicin were used . All patients were in complete remission 1 y after diagnosis.
The BMT study group consisted of 39 patients. Later six patients were excluded from the analyses; two because of recent steroid medication before BMT, and four because of inadequate (non-fasting) blood samples. The 33 patients eligible for analysis included 15 autologous and 18 allogenic transplant recipients. The allogenic donors were 10 HLA-matched siblings and seven matched unrelated donors from the Finnish national registry. One patient received umbilical cord blood stem cell transplant. One autologous patient underwent a double transplant program, but only the ®rst transplantation was included in the lipid status evaluation. Patients transplanted for Wilms' tumor had bilateral disease (Saarinen-Pihkala et al, 1998) . A follow-up of the post-transplant nutritional status of the BMT patients has been published previously (Taskinen & Saarinen, 1996) .
Detailed patient data are presented in Table 1 . The study protocol was approved by the Institutional Review Board. Oral witnessed informed consent was obtained from the parents and age-appropriate patients.
Control subjects
The reference group consisted of 23 healthy Finnish children, 1 ± 3 y of age, admitted to hospital for minor surgery. The normal ranges for lipid and lipoprotein levels, derived from this group, have been published (Antikainen, 1993) .
To create the reference range for fat index, the ultrasonographic thickness of thigh muscle and fat tissue were measured of 58 healthy children (28 males, 30 females), aged 6.1 y (median, range 1.2 ± 15.9 y).
Nutrition
Oral intake of nutrients was encouraged. In tumor patients, additional support of nutrition was instituted when the oral intake was insuf®cient,¯uid and electrolyte disturbances appeared, or the patient was losing weight. The target energy level was determined according to dietary recommendations for healthy children of the same age (Segar, 1972) . Six tumor patients received nutritional support during the neoadjuvant chemotherapy. Five of them received parenteral nutrition, which was given as concentrated glucose (Glucosteril 20% 1 , Orion, Finland), amino acids (Aminosteril 1 , Orion, Finland) and lipids (Intralipid 20% 1 , Pharmacia & Upjohn). The mean quantity of calories provided as lipids was 25% (range 4 ± 42%). The patients also received parenteral electrolytes, vitamins and trace elements. One patient was fed through nasogastric tube with a supplemented tube formula (Semper 1 , Semper AB, Sweden).
Total parenteral nutrition was instituted in every BMT patient on day 1 post-transplant. The median duration of parenteral nutrition was 30 days (range 15 ± 90 days). The guidelines of parenteral nutrition and the target energy levels were the same as in tumor patients.
Laboratory measurements
Venous blood was drawn in the morning between 8 and 10 a.m. in out-patients after an 8 h fast. The blood samples from patients on parenteral nutrition were taken 8 h after discontinuation of lipid infusion. The samples were analyzed immediately. Plasma lipoproteins were separated by sequential ultrasentrifugation using a TFT 45.6 rotor (Kontron, Zurich, Switzerland). Chylomicrons, very-low-density-lipoprotein (VLDL), intermediary-density-lipoprotein (IDL), low-density-lipoprotein (LDL), and HDL were isolated at the densities of 1.006 (13,000 rpma30 min), 1,006 (35,000 rpma18 h), 1.019 (35,000 rpma18 h), 1.063 (35,000 rpma24 h), and 1.21 gamL (35,000 rpma48 h), respectively. An enzymatic assay was used in the measurement of cholesterol and triacylglycerol concentrations in plasma and in lipoprotein fractions (Kits from Boehringer Diagnostica GmbH, Mannheim, Germany). The concentration of serum albumin was measured with the bromcresol purple reaction. The concentrations of prealbumin and transferrin were measured with immunoturbidometric assays (Orion Diagnostica, Espoo, Finland). The normal ranges for serum albumin, prealbumin and transferrin in our laboratory are 34 ± 45 gaL, 170 ± 420 mgaL and 1.75 ± 3.13 gaL, respectively.
Assessment of nutritional status
Nutritional status of tumor patients was assessed on admission and later in remission, 1 ± 2 months after the operation. BMT patients were evaluated before BMT as well as at 1 and 3 months post-transplant. The percentage of weight for height (W%) was derived from the Finnish growth charts (Sorva et al, 1984) . Triceps skinfold thickness as an indicator of body fat stores was measured using a standard procedure (Neuman et al, 1982) . Triceps skinfold is given as a percentage of the age-speci®c mean in Nordic children (Karlberg et al, 1976) . Body fat mass was also estimated by ultrasonography along the measurement of body skeletal muscle protein mass. The skeletal muscle protein mass was expressed as muscle index (MI), which was derived from the measurement of the femoral quadriceps muscle. The thickness of the femoral quadriceps muscle was assessed by ultrasonography (Aloca Echo Camera, model SSD-210 DXII, Aloca Co., Tokyo, Japan; Koskelo et al, 1991) . Due to the increase of muscle thickness with growth, the body size of the children of different ages was taken into account. Thus, the muscle index was estimated from the formula MI QM 2 aS, where QM thickness of quadriceps muscle (cm), and S body surface area (m 2 ) ( Figure  1 ). The reference range of muscle index for healthy children 1 ± 14 y old, using the same method, is 7.5 ± 10.5 cm 2 am 2 ) (Koskelo et al, 1990) . Patients with MI below the group median (5.5 cm 2 am 2 ) were considered to have severely reduced protein reserves. Fat mass was estimated from the formula FI (2QM F 2 )aS, where FI fat index, F thickness of fat tissue on the quadriceps muscle (cm), and QM thickness of quadriceps muscle (cm), measured by ultrasonography. The crosssection of the thigh has been approximated as a circle in both formulas. The formula is mathematically derived from the remainder of two circle surface areas, ie the surface areas formed by the muscle tissue and muscle together with the fat tissue (Figure 1 ). In the literature, no reference range for fat index measured by ultrasonography is available. The fat index of 58 healthy children (median age 6.1 y, range 1.2 ± 15.9 y), measured by ultrasonography for this study, was 6.7 cm 2 am 2 (95% CI 6.0 ± 7.3 cm 2 am 2 ). Puberty was staged according to Tanner (1962) . Throughout the study, both anthropometric and ultrasound measurements were performed by one examiner (MT).
Statistical analyses
The concentrations of lipids and lipoproteins are given as means together with 95% con®dence intervals (95% CI). Analysis of variance (ANOVA, Statview II program) was used in the analyses of repeated measurements. Student's t-test was used to compare the study patients and the reference group. Multiple regression and stepwise regression were used to study the association between lipids and patient characteristics. Linear regression was used to study the correlation between plasma lipids and parameters of nutritional status.
Results
Plasma lipids and lipoproteins in patients with solid tumors
The concentrations of plasma total triacylglycerols were signi®cantly higher in the tumor patients than in the reference group, both at diagnosis (P`0.01, Student's t-test), and in remission (P`0.001, Student' t-test) (Figure 2A ). This was due to triacylglycerol enrichment in VLDL and LDL particles (P`0.01, P`0.001, Student's t-test; Figure 2A ). The concentration of HDL cholesterol was signi®cantly lower in the patients than in the reference group throughout the study period (P`0.001, Student's t-test; Figure 2B ), despite the fact that plasma total cholesterol was within the reference range. The concentration of plasma apolipoproteins Apo AI, ApoAII and ApoB stayed within the reference range ( Figure 2C ).
Plasma lipids and lipoproteins in BMT patients
The pretransplant concentrations of plasma total triacylglycerols were higher in the study patients than in the reference group (P`0.02, Student's t-test; Figure 2A ), due to the higher level of triacylglycerols in VLDL, IDL and LDL lipoprotein fractions (Figure 2A ). The concentration of plasma total cholesterol was within the reference range before transplantation. The concentration of HDL cholesterol was lower in the patients than in the reference group (P`0.001, Student's t-test; Figure 2B ).
The seven patients on steroid treatment for GVHD were excluded from the analyses regarding changes in plasma lipids after BMT. There was a trend to increase in plasma total triacylglycerols during the ®rst three months after BMT (P 0.15, ANOVA; Figure 2A ). The increase was due to triacylglycerol enrichment in LDL during the ®rst post-transplant month (P 0.04, ANOVA), and in HDL fraction from 1 to 3 months after transplantation (P 0.01, ANOVA; Figure 2A ). The concentration of plasma total cholesterol did not change signi®cantly ( Figure 2B ). 
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Concentration of ApoAI and ApoAII were within the reference range before transplantation. During the ®rst post-transplant month the concentration of ApoAI and ApoAII decreased (P 0.001 and P 0.001, respectively, ANOVA) to normalize again during the next 2 months ( Figure 2C ).
The effect of cyclosporin was evaluated by comparing the concentration of plasma lipoproteins after allogeneic transplants without GVHD and steroid treatment (routine CyA prophylaxis, n 11), and after autologous transplants (no CyA, n 15). The concentration of triacylglycerol and cholesterol in various lipoprotein fractions showed no signi®cant difference in patients with or without cyclosporin during the ®rst three months posttransplant.
At evaluation 1 month after BMT, there was no difference in lipid status regardless of ongoing or no parenteral nutrition.
Plasma lipids, lipoproteins and nutritional status: factors associated with increased plasma triacylglycerol concentration Increase of plasma total triacylglycerol concentration was a constant ®nding both in BMT and tumor patients. A multiple regression model was formed for both patient groups separately to ®nd out the factors contributing to the increase. Factors included in the regression model of the pre-BMT patients were gender, pubertal development (prepubertal vs any pubertal advance) and muscle index as representatives of nutritional status (muscle index above or below the group median). In the tumor patients the variants were gender, muscle index and age, because all but one patient were prepubertal.
The strongest single factor in stepwise regression analysis was muscle index in both patient groups. In BMT patients another factor was pubertal development. However, the effect of puberty was highly in¯uenced by one 30% overweight, pubertal patient with plasma total triglycerides of 4.2 mmolal before transplantation. Exclusion of this individual patient from the analysis eliminated the effect of pubertal status, but not the effect of muscle index. Her exclusion did not abolish the signi®cant difference in plasma total triacylglycerol between the patients and the controls. In further analyses, this exceptional patient was excluded. Because the results of multivariant analyses were similar in patients with solid tumors and in patients before BMT, the two groups are combined in the following analyses.
The mean concentrations of serum albumin, prealbumin and transferrin of the combined patient group (solid tumor patients at diagnosis, BMT-patients pretransplant) were 37.2 gal (95% CI 35.4 ± 39.0 gal), 200 mgaCI 180 ± 220 mgal), and 1.85 gal (95% CI 1.68 ± 2.03 gal), respectively. The median MI was 5.5 cm 2 am 2 (range 1.2 ± 12.6 cm 2 am 2 ). In the regression model, MI was the strongest factor associated with plasma triacylglycerol concentration. There was an inverse linear correlation between MI and plasma triacylglycerol concentration (R 0.35, P 0.02; Figure  3 ). Other nutritional parameters, ie W%, triceps skinfold thickness, FI and concentrations of serum transferrin, albumin and prealbumin, did not correlate with plasma triacylglycerol concentration. FI did not correlate with the thickness of the triceps skinfold.
The concentration of serum prealbumin correlated with plasma levels of total cholesterol (R 0.47, P 0.002; Figure 4 ). W%, triceps skinfold thickness and concentration of serum transferrin and albumin had no correlation to plasma total cholesterol concentration.
Discussion
In our pediatric patients with cancer, the most constant abnormalities of lipid metabolism were signi®cantly elevated triacylglycerol and decreased HDL cholesterol concentrations (Figure 2 ). The abnormalities of lipid status were not normalized in remission. Hypertriglyceridemia may result from either increased production, or decreased catabolism of triacylglycerol-rich particles, ie VLDL. In Figure 2 Concentrations of plasma total and fractioned triacylglycerol (A), plasma total and fractioned cholesterol (B), and the concentrations of serum apoproteins AI, AII and B (C). Mean concentration of plasma triacylglycerol with 95% con®dence interval is indicated. TG triacylglycerol, VLDL very low density lipoprotein, IDL intermediate density lipoprotein, LDL low density lipoprotein, HDL high density lipoprotein, CH cholesterol. *P`0.05, **P`0.01, ***P`0.001 in comparison with reference patients.
Plasma lipids in children with cancer MH Taskinen et al cancer, both of these mechanisms may be involved. Increased glucose production, abnormalities in insulin secretion, and enhanced lipolysis have been documented earlier in cancer patients (Kern & Norton, 1988) , so therefore increased endogeneous lipid production might also take place in cancer patients. The above-mentioned metabolic abnormalities are characteristic for insulin resistance (Reaven, 1983) . This condition results in a release of free fatty acids from adipose tissue into the circulation. Fatty acids are taken up by the liver, and are transferred into the triacylglycerol-rich VLDL particles (Reaven, 1983) . Insulin resistance may, as well, result in reduced activity of the enzyme lipoprotein lipase, and subsequently translate in impaired catabolism of VLDL particles (Eckel, 1989) . The proportionate catabolic rate of apoAI, the main apoprotein in HDL particle, is elevated in hypertriglyceridemic subjects (Nikkila È et al, 1987) . Thus, plasma triacylglycerol concentration has a strong inverse correlation to HDL cholesterol levels.
There was a positive correlation between the concentrations of serum prealbumin and plasma total cholesterol (Figure 4 ). This positive correlation has also been observed by Feillet in marasmic children (Feillet et al, 1993) . Prealbumin represents, due to its relatively short half-life, rather the availability of substrate for protein synthesis than body protein reserves (Ingenbleek, 1972) . Cholesterol is the substrate for cell membrane and steroid synthesis (Eisenberg, 1990) . The concentration of plasma cholesterol increases rather rapidly, within a week, during refeeding after severe protein ± energy malnutrition (El Harim et al, 1993) . Serum prealbumin and plasma cholesterol are helpful as parameters of rapid nutritional changes, and in the evaluation of the synthetic activity of the liver and the delivery of substrate to tissues.
An inverse correlation was observed between the concentration of plasma total triacylglycerol and muscle index (Figure 3 ). Decreased activity of lipoprotein lipase might represent the link between the concentration of plasma triacylglycerol and muscle index. Reduced postheparin LPL activity has indeed been documented in cancer patients (Vlassara et al, 1986 ), although we were unable to measure LPL activity in our patients due to ethical reasons considering the patient heparinization for that purpose. LPL, a glycoprotein itself, is the key enzyme in the hydrolysis of triacylglycerols, and is produced mainly by adipose tissue and muscle (Reaven, 1983) . Decreased synthesis of LPL protein results in low plasma LPL activity (Antikainen et al, 1996) . The synthesis of LPL protein might be impaired along with the overall reduction of protein synthesis in muscle tissue of cancer patients. Muscle index and plasma total triacylglycerol seem to be helpful parameters in the evaluation of the patient's nutritional status, metabolic balance and well-being.
We measured body fat mass both using FI and skinfold thickness, which, however, did not have a good correlation with each other. Body fat mass was better reserved than muscle tissue considering the clearly reduced skeletal muscle mass together with a normal body weight and a normal fat index, as estimated either by ultrasonography or the triceps skinfold measurement. The skinfold-based estimates of muscle mass have also proven inaccurate in the measurement of body muscle protein mass in cancer patients (Taskinen & Saarinen-Pihkala, 1998a) . The relative preservation of adipose tissue is, however, hard to explain without any measurements of energy metabolism. Incomplete adaptation to prolonged energy deprivation with excess use of glucose and amino acids compared to fat-derived substrates as source of energy (Young, 1977; Heber et al, 1986 ) might result in loss of muscle and preservation of adipose tissues. Whatever the mechanism, it seems to continue beyond the cancer treatment. Patients treated for cancer in childhood seem to be prone to overweight and serum lipid pathology also later in their life (Talvensaari et al, 1996) . 
Plasma lipids in children with cancer MH Taskinen et al
Muscle index is a rather newly discovered parameter as an indicator of nutritional status. However, it has proved to be an accurate estimate of the largest protein reserve of body, the skeletal muscle (Koskelo et al, 1991) . Decrease in muscle index reveals loss of skeletal muscle protein reserve before the traditional anthropometric methods show any change in nutritional status (Taskinen & SaarinenPihkala, 1998a ). Furthermore, we have shown that poor muscle index is associated with impaired post-transplant growth velocity (Taskinen & Saarinen-Pihkala, 1998b) , and increased relapse mortality after bone marrow transplantation (Taskinen & Saarinen, 1996) . In the present study, we show the close correlation between lipid and protein metabolisms by using muscle index as a parameter. Thus, muscle index has a crucial role as an indicator of nutritional status, and we are advocating assessment of skeletal muscle protein mass by this method.
We conclude that in children with cancer, abnormalities of lipid status are associated with changes in protein reserves in skeletal muscle. Reduced muscle index together with hypertriglyceridemia is an indicator of severe nutritional and metabolic disturbance. Adequate follow-up of nutritional status and metabolic parameters should include assessment of both protein and lipid status.
